Company intelligence / Profile preview

IN2BIO

Ownership: Private
Development stage: Commercial

Overview

IN2BIO develops and tests new bio-converted sources and natural extracts for use in cosmetic products, focusing on efficacy testing and maximizing the effectiveness of naturally derived ingredients. The company collaborates with local universities and government agencies on research into skin aging, leading to new product launches based on these studies.

Therapeutic areas: Dermatology
Modalities: Natural extractsBio-converted materialsSmall molecule
Industry: Non-Drug Biotech

Partnerships

Collaborative research with local universities and government agencies focused on cosmetic applications of bioactive materials. No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on IN2BIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IN2BIO.

Explore the full profile